Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief R&D Officer
-
Stock Symbol
-
NKTR on Nasdaq
Jonathan Zalevsky - trading volume in the past year for Nektar Therapeutics
Holdings reported by Jonathan Zalevsky for Nektar Therapeutics
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
243K |
$245K |
$1.01 |
Nov 19, 2024 |
Direct |
|
|
| Stock Option |
250K |
|
|
Dec 13, 2023 |
Direct |
Common Stock |
|
Transactions reported by Jonathan Zalevsky for Nektar Therapeutics
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.